3 New Strong Buy Ratings from Top-Rated Analysts: 11/13/2026

Just enough time to check these out before the market closes…

• Crescent Energy (CRGY): Experts project 80% upside following a high-profile deal
• Matson (MATX): A top stock in a trending industry 
• Omada Health (OMDA): Experts believe this stock could double or more

P.S. Get more alerts like this daily … Try WallStreetZen Premium.

A note from our sponsors...

America's Economist Explains This Stock Market in Three Words

Something strange is happening in the stock market. Dr. Mark Skousen, the economist who called the '95 tech boom and the 2009 bottom, has boiled it down to three words. And if he's right, what happens next could make or break your retirement.

Watch the one move he says to make now – free, right here.

1. Crescent Energy (NYSE: CRGY)

This diversified oil and gas company is capitalizing on favorable energy market conditions and operational efficiency gains to drive shareholder value.

Zen Rating: A (Strong Buy) — see full analysis

Recent Price: $11.61 — get current quote

Max 1-year forecast: $24.00

Why we're watching: 

• CRGY has solid, bullish coverage among the analysts we track, with 6 Strong Buy, 2 Buy, and 1 Hold recommendations. See all recommendations here
• For example, Raymond James researcher John Freeman (a top 1% rated analyst) maintained his Strong Buy recommendation with a price target more than 80% above current levels.  
• Industry ranking context: CRGY is currently the #7 highest-rated stock in the Oil and Gas industry, which has an Industry Rating of B.
• Zen Ratings highlights: CRGY earns an overall A rating, which amounts to a Strong Buy recommendation. Stocks in this topmost tier have historically delivered nearly 30% annual returns, soundly beating the S&P.
• Component Grades: CRGY excels for Growth with an A grade, reflecting the company's strong expansion trajectory in the energy sector, while maintaining solid Bs for Sentiment and Value, a combination that positions it well for continued appreciation. See all 7 Component Grades here

2. Matson (NYSE: MATX)

This massive freight company continues to benefit from strong demand in its core markets and operational excellence that drives consistent profitability.

Zen Rating: A (Strong Buy) — see full analysis

Recent Price: $212.03 — get current quote

Max 1-year forecast: $310.00

Why we're watching:

• MATX has limited, but overall bullish, coverage among the analysts we track, with 3 Strong Buy recommendations. See all recommendations here
• For example, Freedom Broker researcher Sergey Glinyanov (a top 6% rated analyst) initiated coverage with a Strong recommendation and a price target more than 25% above current levels. 
• Industry ranking context: MATX is currently the #11 highest-rated stock in the Shipping industry, which has an Industry Rating of A.
• Zen Ratings highlights: MATX earns an overall A rating, which is equal to a Strong Buy recommendation. This rating represents the elite top 5% of all 4,600+ stocks tracked based on a rigorous 115-factor fundamental review.
• Component Grades: MATX demonstrates strong Bs for Financials and Momentum, alongside an exceptional A for Artificial Intelligence, positioning the company well for technological advancement and operational efficiency gains in the shipping sector. See all 7 Component Grades here

3. Omada Health (NASDAQ: OMDA)

This virtual healthcare-focused company is capitalizing on the growing digital health market and expanding its member base through strong partnerships with health plans and employers.

Zen Rating: A (Strong Buy) — see full analysis

Recent Price: $15.06 — get current quote

Max 1-year forecast: $35.00

Why we're watching:

• OMDA has solid, bullish coverage among the analysts we track, with 6 Strong Buy, 2 Buy, and 2 Hold recommendations. See all recommendations here
• For example, Barclays researcher Saket Kalia (a top 2% rated analyst) maintained his Strong Buy recommendation with a price target suggesting the stock has over 40% upside potential from current levels.
• Better still, BTIG researcher David Larsen (a top 14% rated analyst) reiterated his Strong Buy with a price target over 130% above current levels. 
• Industry ranking context: OMDA is currently the #5 highest-rated stock in the Health Information Service industry, which has an Industry Rating of A.
• Zen Ratings highlights: OMDA earns an overall A rating, which equals a Strong Buy recommendation. Stocks with this grade represent the elite performers based on a comprehensive 115-factor fundamental analysis framework.
• Component Grades: OMDA stands out with an A grade for Sentiment, reflecting strong analyst confidence and market positioning, while maintaining solid Bs for Financials and Growth, a mix that supports its digital health expansion strategy. See all 7 Component Grades here

What to Do Next?

• 77 Best Stocks NOW! >
• Options Trading with the Zen Ratings >
• 2 New Stocks to Buy from Steve Reitmeister >

Want to get in touch? Email us at news@wallstreetzen.com.